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INTRODUCTION
Graves’ disease (GD) is an autoimmune disease presented
by hyperthyroidism. Although the etiology and pathogene-
sis of GD are still not clear, environmental factors including
virus infection are suggested to be involved (1). Among these,
retrovirus, enterovirus (especially Coxsackie B virus), and
influenza B virus were reported with serologic evidence (2-
4). However, there has been no report on hantaan virus infec-
tion with GD. The hantaan virus is common in South Korea
and can cause hemorrhagic fever with renal syndrome (HFRS)
(5).
We herein describe the first case of HFRS with GD asso-
ciated with hantaan virus infection.
CASE REPORT
A 19-yr-old man was admitted to Chonbuk National Uni-
versity Hospital, South Korea with fever, dyspnea, palpitation,
sweating, and drowsiness. On admission his vital signs were
blood pressure 140/90 mmHg, heart rate 136/min, body
temperature 38.1℃, and respiratory rate 45/min. On phys-
ical examination, the patient appeared acutely ill and pre-
sented with petechiae in the throat, erythematous rash on
the body, conjunctival suffusion without eyeball protrusion,
mild non-tender swelling of the neck area with thrill, and
abdominal tenderness with hepatosplenomegaly. Before ad-
mission, he had no medical problems and had no family his-
tory of medical disease. Recently, his parents observed the
patient’s trend of weight loss and irritability, but he had no
complaint of his health status. Laboratory findings are shown
in Table 1. The patient was treated with fluid therapy in bal-
ance with urine output, empirical antibiotics, methimazole,
and non-selective beta blocker. On day 4, hypothermia and
hypotension occurred, and on day 6, oliguria developed. How-
ever, the patient was tolerable and so supportive fluid thera-
py was continued with the monitoring of urine amount. Thy-
roid ultrasonography and scan were also performed (Fig. 1),
which showed findings compatible with hyperthyroidism.
On day 14, the patient was stabilized in terms of physical
and laboratory findings (Fig. 2, Table 1) and was discharged
with complete recovery on day 21. Before discharge, the titer
of hantaan virus and thyroid function test including thy-
rotropin binding inhibitory immunoglobulin (TBII) were
re-checked (Table 1) and the results strongly showed that
the diagnosis of GD and hantaan virus infection and treat-
ment targeting to these diseases had been reasonable.
DISCUSSION
GD is an organ-specific autoimmune disease and charac-
terized by autoimmune hyperthyroidism caused by thyroid-
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A Case of Graves’ Disease Combined with Hantaan Virus Infection
Graves’ disease (GD) is generally presented by thyrotoxicosis with hyperthyroidism,
and it is an organ-specific autoimmune disease induced by thyroid-stimulating hor-
mone receptor autoantibodies. However, among diverse etiologies, viral infections
have been suggested to trigger or to be involved in the pathogenesis of GD. Han-
taan virus infection causing hemorrhagic fever with renal syndrome (HFRS) is com-
mon in South Korea and its pathogenesis is suggested to be an immunologic mech-
anism. We have experienced a patient who was diagnosed as HFRS with thyro-
toxicosis. So we herein report the case as GD combined with the hantaan virus
infection.
Key Words : Graves’ Disease; Hemorrhagic Fever with Renal Syndrome; Hantaan Virus
Received : 25 July 2007
Accepted : 18 January 2008stimulating hormone (TSH) receptor autoantibody and sever-
al cytokines such as interleukin-1 (IL-1), tumor necrosis fac-
tor-alpha (TNF-α ), and interferon-gamma (IFN-γ ) were re-
ported to be involved in the activation of TSH receptor (1,
6). In addition, both genetic and environmental factors are
also believed to contribute to the development of GD; how-
ever, etiologies and pathogenesis remain unclear (6). Recent-
ly, several studies have suggested that viral infection may be
involved in the pathogenesis of GD (2-4). Evidence that infec-
tion might be related with GD has been shown by epidemi-
ology, serology, and molecular methods. Proposed possible
mechanisms are molecular mimicry between the TSH recep-
tor and viral antigen, superantigenic stimulation of autoreac-
tive lymphocytes (T cell activation), anti-idiotypic antibodies
reactive with the TSH receptor (6, 7), formation of immune
complexes or induction of immune response (8), and induc-
tion of classs II major histocompatibility complex (MHC)
antigen on thyrocytes (9, 10). However, hantaan virus infec-
tion causing HFRS has not been reported as a triggering
factor of GD.
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Fig. 1. Thyroid ultrasonography using 7.5 MHz probe and 99m-Tc (technecium) thyroid scan of the patient. (A) The anteroposterior diam-
eter of the isthmus was increased to 6 mm. (B) The right lobe showed heterogenic echogenecity with increased vascularity and enlarged
size. (C) The left lobe showed thyroid inferno and both lobes showed the same findings. (D) Both lobes showed increased trapping with-
out a nodular region.
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Hantaan viruses are found wherever rodents of the family
Muridae are present and can cause HFRS through aerosols
of infectious rodent urine (5). The pathogenesis of hantaan
virus infection is still unclear, however, an immunopatho-
logic process has been suggested to be one of the involved
mechanisms. Hantaan virus infection also causes clinical rep-
resentations by diverse mediators such as TNF-α , and IFN-
γ , IL-4, and IL-6 (11). In this respect, as with other known
TBII: thyrotropin binding inhibitory immunoglobulin; tested by thyrotropin receptor autoantibodies kit using 
125I-labelled TSH produced from RSR Ltd.,
Cardiff, U.K. Hantaan virus; tested by Genedia Hantadia
� (Greencross, South Korea).
AST, aspartate aminotransferase; ALT, alanine aminotransferase; Bun/Cr, blood urea nitrogen/creatinine; CRP, c-reactive protein; TSH, thyroid stimu-
lating hormone.
At admission Day 3 Day 7 Day 14 Day 21
Urine out (mL/day)
1,000 1,500 450 4,500 1,500
Hematuria ++ + -- -
Proteinuria Trace Trace 1+ Trace -
Leukocyte (/μ L) 13,500 11,100 3,440 4,500 5,300
Hemoglobin (g/dL) 10.3 8.7 10.0 10.6 11.5
Platelet (/μ L) 54,000 69,000 11,000 88,000 248,000
AST/ALT (IU/L) 35/41 463/995 133/634 92/120 58/45
Total protein (g/dL) 5.3 5.4 6.2 6.4 6.4
Albumin (g/dL) 2.9 3.1 3.3 3.3 3.4
Bun/Cr (mg/dL) 23.8/0.5 18/1.0 24/1.9 20/1.1 5/0.4
CRP (mg/L) 9.79 6.4 1.2
TSH (N: 0.17-4.05 μ U/mL) 0.008 0.01
TBII (N: 0-9.0 unit) >405 >405
FT4 (N: 9.4-25 pM/L) 99.86 43.4
Hantaan virus 1:640 1:2,560
Table 1. Laboratory findings of the patient during admission 
Fig. 2. Vital signs during hospitalization. (A) Body temperature
change. (B) Systolic (Sys) and diastolic (Dia) blood pressure (BP)
and heart rate (HR) changes. (C) Urine output change.
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viruses, hantaan virus can also be involved in the pathogen-
esis of GD, although the exact mechanism and mediating
factors are not known. In this case, the patient was diagnosed
as HFRS due to hantaan virus infection by laboratory findings
and clinical course.
In summary, we herein report a case of HFRS caused by
hantaan virus infection presenting simultaneously with GD.
However, further research is needed to find etiologic factors
in induction of GD with a direct approach using infecting
organism isolation to determine whether it was triggered
by a hantaan virus infection. Also, a retrospective analysis of
HFRS or GD about combined diseases or prospective inves-
tigation of GD with hantaan virus infection or HFRS with
thyrotoxicosis should be performed to demonstrate the causal
relationship between hantaan virus infection and GD.
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